An observational study in HIV and Lipodystrophy, sponsored by University Hospitals Cleveland Medical Center. Completed at 1 site in United States. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2026-01-28.
Sponsored by University Hospitals Cleveland Medical Center · Observational
In this observational study, the investigators will examine the changes in body composition in HIV-infected subjects before and after initiation of HIV treatment, and look at the correlations with changes in cardiometabolic indices such as endothelial function and coronary calcium scoring.
The effects of lifestyle factors on body composition changes after antiretroviral therapy (ART) are unknown, and as such, investigators will use this prospective observational cohort to study relationships between lifestyle factors, including diet, physical activity and illicit drug use, with changes in body composition after ART. In addition, the effect of the body fat changes will be correlated to changes in cardiometabolic indices such as endothelial function and coronary calcium scoring.
Subjects will be primarily recruited from the practice of the investigator (the Special Immunology Unit (SIU) at University Hospitals Case Medical Center). All subjects seen at the Special Immunology Unit who meet the inclusion/exclusion criteria will be approached for study participation. Subjects who see physicians outside of the SIU may be eligible as well if they contact the study team and meet the inclusion criteria.
Exclusion Criteria:
HIV-infected subjects ≥ 16 years who are ART-naïve starting their first antiretroviral regimen
Diagnostic Test: Dual-energy X-ray absorptiometry
Body composition measures
Assessed using DEXA (dual energy x-ray absorptiometry) scans which will be quantifying total body fat
Time frame: Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year
Resting Energy Expenditure (REE) measures
Assessed using a BodyGem REE calculator (values in KCal)
Time frame: Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year
endothelial function measures
Assessed using EndoPAT (values reported as a reactive hyperemia index RHI)
Time frame: Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year
calcium score measures
Assessed using CT scans
Time frame: Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year
central obesity
measured with waist circumference using a tape measure (in cm)
Time frame: Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year
Lipids measures
used measuring blood levels of triglycerides (mg/dL); serum high-density lipoprotein (mg/dL) ; cholesterol (mg/dL); low density lipoprotein (mg/dL)
Time frame: Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year
Fasting plasma glucose measures
fasting plasma glucose test is performed after a person has fasted for at least 8 hours (measured in mg/dL)
Time frame: Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year
Metabolic syndrome
Metabolic syndrome will be defined using the following measures: central obesity, serum triglycerides , serum high-density lipoprotein (HDL); cholesterol levels and fasting plasma glucose
Time frame: Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospitals Cleveland Medical Center